G. Ferreira

An Immunostimulatory Glycolipid That Blocks SARS-CoV-2, RSV, and In�uenza Infections In Vivo

Munemasa Mori, Yaoxing Huang, M. Nair, 2023 .

In silico and in vitro arboviral MHC class I-restricted-epitope signatures reveal immunodominance and poor overlapping patterns

M. Tsuji, E. Barbosa-Stancioli, F. D. da Fonseca, 2022, Frontiers in Immunology.

Timeline Kinetics of Systemic and Airway Immune Mediator Storm for Comprehensive Analysis of Disease Outcome in Critically Ill COVID-19 Patients

A. Teixeira-Carvalho, Thais F. C. Fraga-Silva, Fernanda Mesquita de Souza, 2022, Frontiers in Immunology.

Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19

E. Gross, J. C. Dias, A. P. D. de Lemos, 2021, Biomedicine & Pharmacotherapy.